Yahoo
NYSE American - Nasdaq Real Time Price USD

Retractable Technologies, Inc. (RVP)

0.5650 -0.0113 (-1.96%)
At close: October 30 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for RVP
  • Previous Close 0.5763
  • Open 0.5900
  • Bid 0.5650 x 40000
  • Ask 0.6994 x 10000
  • Day's Range 0.5650 - 0.5824
  • 52 Week Range 0.5650 - 0.9000
  • Volume 33,271
  • Avg. Volume 30,764
  • Market Cap (intraday) 16.914M
  • Beta (5Y Monthly) 1.31
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1200
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and national direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

www.retractable.com

195

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

RVP
26.62%
S&P 500 (^GSPC)
10.73%

1-Year Return

RVP
35.06%
S&P 500 (^GSPC)
11.11%

3-Year Return

RVP
48.64%
S&P 500 (^GSPC)
81.91%

5-Year Return

RVP
94.03%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY10
Revenue 8.07M
Earnings --
Profit Margin 0.00%

Q4

FY10

0
2M
4M
6M
8M
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -9.94%

  • Return on Assets (ttm)

    -9.40%

  • Return on Equity (ttm)

    -4.51%

  • Revenue (ttm)

    33.9M

  • Net Income Avi to Common (ttm)

    -3.6M

  • Diluted EPS (ttm)

    -0.1200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    39.87M

  • Total Debt/Equity (mrq)

    1.34%

  • Levered Free Cash Flow (ttm)

    2.16M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: